A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report

Charles Bonnet syndrome (CBS) is a diagnosis of exclusion. Typical affected patients have impaired visual acuity, vivid recurring visual hallucinations, and no cognitive impairment. Vision loss is most commonly due to macular degeneration, although many other causes exist. Here, we report a case of...

Descripción completa

Detalles Bibliográficos
Autor principal: Alamri, Sultan H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865558/
https://www.ncbi.nlm.nih.gov/pubmed/29593414
http://dx.doi.org/10.2147/NDT.S161124
_version_ 1783308703247630336
author Alamri, Sultan H
author_facet Alamri, Sultan H
author_sort Alamri, Sultan H
collection PubMed
description Charles Bonnet syndrome (CBS) is a diagnosis of exclusion. Typical affected patients have impaired visual acuity, vivid recurring visual hallucinations, and no cognitive impairment. Vision loss is most commonly due to macular degeneration, although many other causes exist. Here, we report a case of an 87-year-old woman with CBS and discuss the diagnosis and treatment.
format Online
Article
Text
id pubmed-5865558
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-58655582018-03-28 A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report Alamri, Sultan H Neuropsychiatr Dis Treat Case Report Charles Bonnet syndrome (CBS) is a diagnosis of exclusion. Typical affected patients have impaired visual acuity, vivid recurring visual hallucinations, and no cognitive impairment. Vision loss is most commonly due to macular degeneration, although many other causes exist. Here, we report a case of an 87-year-old woman with CBS and discuss the diagnosis and treatment. Dove Medical Press 2018-03-20 /pmc/articles/PMC5865558/ /pubmed/29593414 http://dx.doi.org/10.2147/NDT.S161124 Text en © 2018 Alamri. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Case Report
Alamri, Sultan H
A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report
title A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report
title_full A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report
title_fullStr A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report
title_full_unstemmed A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report
title_short A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report
title_sort low dose of risperidone resolved charles bonnet syndrome after an unsuccessful trial of quetiapine: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865558/
https://www.ncbi.nlm.nih.gov/pubmed/29593414
http://dx.doi.org/10.2147/NDT.S161124
work_keys_str_mv AT alamrisultanh alowdoseofrisperidoneresolvedcharlesbonnetsyndromeafteranunsuccessfultrialofquetiapineacasereport
AT alamrisultanh lowdoseofrisperidoneresolvedcharlesbonnetsyndromeafteranunsuccessfultrialofquetiapineacasereport

Ejemplares similares